Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer
Advanced Science · 2025-03 · 12 (12)
DOI: 10.1002/advs.202408845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 31.01.2025. Verfasst von Zhou Yang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Ferroptosis, Histone Deacetylase Inhibitors, Colorectal Neoplasms, Apoptosis Regulatory Proteins. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai Anticancer Association.
Abstract (Originalsprache)
Colorectal cancer (CRC) is highly resistant to ferroptosis, which hinders the application of anti‐ferroptosis therapy. Through drug screening, it is found that histone deacetylase inhibitor (HDACi) significantly sensitized CRC to ferroptosis. The combination of HDACi and ferroptosis inducers synergically suppresses CRC growth both in vivo and in vitro. Mechanically, HDACi reduces ferroptosis suppressor protein (FSP1) by promoting its mRNA degradation. Specifically, it is confirmed that HDACi specifically targets HDAC1 and promotes the H3K27ac modification of fat mass‐ and obesity‐associated gene (FTO) and AlkB Homolog 5, RNA Demethylase (ALKBH5), which results in significant activation of FTO and ALKBH5. The activation of FTO and ALKBH5 reduces N6‐methyladenosine (m 6 A) modification on FSP1 mRNA, leading to its degradation. Crucially, lactylation of HDAC1 K412 is essential for ferroptosis regulation. Both Vorinostat (SAHA) and Trichostatin A (TSA) notably diminish HDAC1 K412 lactylation in comparison to other HDAC1 inhibitors, exhibiting a consistent trend of increasing susceptibility to ferroptosis. In conclusion, the research reveals that HDACi decreases HDAC1 K412 lactylation to sensitize CRC to ferroptosis and that the combination of HDACi and ferroptosis inducers can be a promising therapeutic strategy for CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
- Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
- Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, 214043, China.
- Department of Integrative Medicine, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, 200433, China.
- Department of Medical Oncology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, China.
ORCID-Profile: Bing Yao
Förderung
- Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Shanghai Anticancer Association
- Natural Science Foundation of Jiangsu Province
- The General Program of Wuxi Medical Center, Nanjing Medical University
- The General Program of Wuxi Medical Center
- Major Research Projects of Taizhou Clinical Medical College
- National Natural Science Foundation of China
Zitieren
APA
Yang, Z., Su, W., Zhang, Q., Niu, L., Feng, B., Zhang, Y., Huang, F., He, J., Zhou, Q., Zhou, X., Ma, L., Zhou, J., Wang, Y., Xiong, W., Xiang, J., Hu, Z., Zhan, Q., & Yao, B. (2025). Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer. Advanced Science, 12(12). https://doi.org/10.1002/advs.202408845
Vancouver
Yang Z, Su W, Zhang Q, Niu L, Feng B, Zhang Y, et al. Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer. Advanced Science. 2025;12(12). doi:10.1002/advs.202408845
BibTeX
@article{Yang2025,
author = {Yang, Zhou and Su, Wei and Zhang, Qinglin and Niu, Lili and Feng, Baijie and Zhang, Yu and Huang, Feng and He, Jiaxin and Zhou, Qinyao and Zhou, Xin and Ma, Longjun and Zhou, Jingwan and Wang, Yuanrong and Xiong, Wenjing and Xiang, Jun and Hu, Zhilin and Zhan, Qiang and Yao, Bing},
title = {Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {12},
doi = {10.1002/advs.202408845}
}
EUVIMED